Interpharm Holdings Company Top Insiders

Interpharm Holdings Management Team Effectiveness

The company has return on total asset (ROA) of (0.1853) % which means that it has lost $0.1853 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1707) %, meaning that it created substantial loss on money invested by shareholders. Interpharm Holdings' management efficiency ratios could be used to measure how well Interpharm Holdings manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.23. The Interpharm Holdings' current Return On Capital Employed is estimated to increase to -0.27. As of now, Interpharm Holdings' Intangibles To Total Assets are decreasing as compared to previous years. The Interpharm Holdings' current Debt To Assets is estimated to increase to 0.34, while Other Current Assets are projected to decrease to under 18 K. The Interpharm Holdings' current Net Loss is estimated to increase to about (14.4 M)Some institutional investors establish a significant position in stocks such as Interpharm Holdings in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Interpharm Holdings, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Interpharm Holdings Workforce Comparison

Interpharm Holdings Profit Margins

The company has Profit Margin (PM) of (0.42) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.24) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.24.

Interpharm Holdings Benchmark Summation

Interpharm Holdings Stakeholder

String symbol = request.getParameter("s");

The success or failure of an entity such as Interpharm Holdings often depends on how effective the management is. Interpharm Holdings management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Interpharm management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Interpharm management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Interpharm Holdings' price analysis, check to measure Interpharm Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Interpharm Holdings is operating at the current time. Most of Interpharm Holdings' value examination focuses on studying past and present price action to predict the probability of Interpharm Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Interpharm Holdings' price. Additionally, you may evaluate how the addition of Interpharm Holdings to your portfolios can decrease your overall portfolio volatility.